Literature DB >> 6611406

Isolated perfused rabbit coronary artery and aortic strip preparations: the role of endothelium-derived relaxant factor.

T M Griffith, A H Henderson, D H Edwards, M J Lewis.   

Abstract

Isolated perfused coronary arteries and aortic ring preparations of rabbits were studied, both with intact endothelium and with endothelium removed by K-rich solution and friction respectively. Constrictor dose-responses to histamine, acetylcholine, phenylephrine and 5-hydroxytryptamine (5-HT) were measured. They were greatly depressed by the presence of endothelium in coronary preparations. In aortic preparations endothelium affected dose-responses relatively little, depressing the response to acetylcholine but apparently increasing the responses to the other three agents. Acetylcholine relaxed pre-constricted coronary or aortic preparations but only when endothelium was present. This relaxation was inhibited by quinacrine or hydroquinone. Aortic preparations had resting tone which could be increased by hydroquinone if endothelium was present, suggesting continual release of endothelium-derived relaxant factor (EDRF) at rest. When allowance was made for basal EDRF activity in aortic preparations, the maximal constrictor response to acetylcholine remained lower in the presence of endothelium, consistent with acetylcholine stimulation of EDRF, but maximal constrictor responses to the other three agents were the same with and without endothelium, suggesting that the direct constrictor response overrides EDRF activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611406      PMCID: PMC1193100          DOI: 10.1113/jphysiol.1984.sp015228

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  12 in total

1.  Inhibitory effect of a calcium antagonist (diltiazem) on aortic and coronary contractions in rabbits.

Authors:  M Sato; M Ohashi; M Z Metz; R J Bing
Journal:  J Mol Cell Cardiol       Date:  1982-12       Impact factor: 5.000

2.  Vascular endothelium and the relaxation effect of histamine on aorta of the rat.

Authors:  J Van de Voorde; I Leusen
Journal:  Arch Int Pharmacodyn Ther       Date:  1982-04

3.  Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries.

Authors:  J G De Mey; P M Vanhoutte
Journal:  J Physiol       Date:  1981-07       Impact factor: 5.182

4.  Role of endothelial cells in relaxation of isolated arteries by bradykinin.

Authors:  P D Cherry; R F Furchgott; J V Zawadzki; D Jothianandan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

6.  Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin.

Authors:  T M Cocks; J A Angus
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

7.  Spectrum of coronary arterial spasm. Clinical, angiographic and myocardial metabolic experience in 29 cases.

Authors:  L Wiener; H Kasparian; P R Duca; P Walinsky; R S Gottlieb; F Hanckel; A N Brest
Journal:  Am J Cardiol       Date:  1976-12       Impact factor: 2.778

8.  Sensitivity to indomethacin of tetrodotoxin-resistant contractions of smooth muscle from the base of rabbit bladder.

Authors:  J W Downie; B E Slack
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

9.  Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium.

Authors:  J G De Mey; P M Vanhoutte
Journal:  Circ Res       Date:  1982-10       Impact factor: 17.367

Review 10.  Dynamic coronary tone in precipitation, exacerbation and relief of angina pectoris.

Authors:  S E Epstein; T L Talbot
Journal:  Am J Cardiol       Date:  1981-10       Impact factor: 2.778

View more
  38 in total

1.  Effect of endothelium removal on the vasoconstrictor response to neuronally released 5-hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries.

Authors:  M Urabe; H Kawasaki; K Takasaki
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

Review 2.  St Cyres lecture. Endothelium in control.

Authors:  A H Henderson
Journal:  Br Heart J       Date:  1991-03

3.  Effects of prostaglandin I2 synthesized in the endothelium and in the smooth muscle on mechanical properties of the canine thoracic aorta.

Authors:  M Domae; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

4.  Endothelium in control.

Authors:  C Borland
Journal:  Br Heart J       Date:  1991-11

5.  Mechanism of 5-hydroxytryptamine-induced coronary vasodilation assessed by direct detection of nitric oxide production in guinea-pig isolated heart.

Authors:  A J Ellwood; M J Curtis
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

6.  Effects of exercise training on responsiveness of the mesenteric arterial bed to phenylephrine and KCl in male rats.

Authors:  C Jansakul; P Hirunpan
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

7.  Detergent and methylene blue affect endothelium-dependent vasorelaxation and pressure/flow relations in rat blood perfused mesenteric arterial bed.

Authors:  M D Randall; C R Hiley
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

Review 8.  Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.

Authors:  L J Ignarro
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

Review 9.  Endothelium-derived relaxing factor and the pulmonary circulation.

Authors:  G Cremona; A T Dinh Xuan; T W Higenbottam
Journal:  Lung       Date:  1991       Impact factor: 2.584

10.  Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.

Authors:  D W Gray; I Marshall
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.